Please login to the form below

Not currently logged in
Email:
Password:

New appointment at ABPI

The Association of the British Pharmaceutical Industry has appointed Sam Ogden as membership engagement account director

The Association of the British Pharmaceutical Industry (ABPI) has announced the appointment of Sam Ogden as membership engagement account director. Sam will join the ABPI on January 10, 2011 and she will be reporting to Alison Clough, ABPI commercial director.

Sam is currently head of in-field effectiveness at Roche where she has worked for the past 10 years in a variety of senior sales, marketing and business unit head roles. Prior to joining Roche, Sam held commercial roles at AstraZeneca and SmithKline Beecham.

Alison Clough said: "We are delighted that Sam will be joining us. She brings a wide range of experience including primary and secondary care sales and marketing, market research and sales force effectiveness. Sam will ensure that we engage more proactively with all our members, in particular the small to mid-sized companies and will play a key role in ensuring their views and needs are fully represented in our campaigns."

Meanwhile, former ABPI president Chris Brinsmead has been appointed as the government's new life sciences business adviser, helping the government to deliver a UK life sciences environment that promotes innovation and sector growth and ensures that patients have access to the latest medicines and medical technologies.

24th November 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics